![Srdx qtr date](https://loka.nahovitsyn.com/245.jpg)
The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications.
![srdx qtr date srdx qtr date](http://media.liveauctiongroup.net/i/29686/25859072_2.jpg)
![srdx qtr date srdx qtr date](https://www.dxlabsuite.com/Wiki/Graphics/DXKeeper/QSLMsgCard.jpg)
#SRDX QTR DATE ANDROID#
Revenue fell 25.4 compared to the same quarter a year ago. BMW / NBT EVO ID5/6 (production date 07/2016+ )APPLE WIRELESS CARPLAY,VIDEO IN MOTION AT ALL SPEEDS, ANDROID SCREEN MIRRORING ACTIVATION VIA USB All Card. The consensus estimate was a loss of 0.32 per share on revenue of 24.4 million. (NASDAQ:SRDX) shareholders might be concerned after seeing the share price drop 10 in the last quarter. Revenue from our Medical Device business group 5 year-over-year to 17.5. Last quarter the company beat on EPS by 0.12 which was followed by a. This particular version features a max output of 272 horsepower and 280 pound-feet of torque. Revenue was up 981 thousand from the same period last year. The 2023 Acura RDX will continue with the well-known, turbocharged version of the legendary K20 engine. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. Surmodics (SRDX) reported a 2nd Quarter March 2022 loss of 0.22 per share on revenue of 26.1 million. Revenue for the third quarter of fiscal 2022 grew 4 to 24.9, compared to 23.9 million in the prior year quarter. The current model offers very good performance and there is really no need for changes in this aspect. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. a fully franked dividend of 1.35 cents per share for the June quarter. The 4 analysts offering 12-month price forecasts for Surmodics Inc have a median target of 68.00, with a high estimate of 114.00 and a low estimate of 46.00. State of New Jersey Common Pension Fund D (NASDAQ:SRDX), a leading provider of medical. Healthcare of Ontario Pension Plan Trust Fund Surmodics Institutional Trading History Reporting DateĪllspring Global Investments Holdings LLCĬalifornia State Teachers Retirement SystemĬharles Schwab Investment Management Inc.Ĭommonwealth of Pennsylvania Public School Empls Retrmt SYS Surmodics Insider Trading History Transaction Date As of this date, TyRx has filed 3 patent applications covering products targeting cardiovascular and cosmetic surgical applications.
![Srdx qtr date](https://loka.nahovitsyn.com/245.jpg)